# Merck & Co

commercialized pembrolizumab (Keytruda), the world's largest-selling immuno-oncology monoclonal antibody and a flagship of recombinant mammalian-cell biomanufacturing.


Source: https://en.bioecon.ru/companies/merck-co/
Updated: 2026-07-29

- Country: United States

## Technologies

- [Biopharmaceuticals & biomedicines](https://en.bioecon.ru/technology/biopharmaceuticals-biomedicines/)